Publicacions en col·laboració amb investigadors/es de Hospital Universitario de Salamanca (26)

2024

  1. Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease

    British Journal of Haematology, Vol. 205, Núm. 1, pp. 109-121

2023

  1. Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study

    Cancer Medicine, Vol. 12, Núm. 6, pp. 6536-6546

  2. [18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 11, pp. 3439-3451

2022

  1. The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 2, pp. 126-135

  2. Usefulness of the FDG PET/CT in the management of cystic echinococcosis: A pilot study

    Acta Tropica, Vol. 227

2021

  1. 18F-FDG PET/CT in ovarian cancer recurrence: Clinical impact, correlation with ceCT and CA-125, and prognostic value

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 4, pp. 207-213

  2. Genetic complexity impacts the clinical outcome of follicular lymphoma patients

    Blood Cancer Journal

  3. Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping

    British Journal of Haematology, Vol. 195, Núm. 4, pp. 542-551

2020

  1. Biological features and prognostic impact of bone marrow infiltration in patients with diffuse large b-cell lymphoma

    Cancers, Vol. 12, Núm. 2

  2. Medicina Nuclear: Diagnóstico de la patología de tiroides y paratiroides

    Revista ORL, Vol. 11, Vol. 3, pp. 283-295

  3. Tratamiento con radioyodo de la patología tiroidea

    Revista ORL, Vol. 11, Vol. 3, pp. 305-327

2019

  1. 18F-FDG PET/CT of Lung Adenocarcinoma with Ovarian Metastases

    Clinical Nuclear Medicine, Vol. 44, Núm. 5, pp. 397-398

  2. Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

    Blood Cancer Journal, Vol. 9, Núm. 7

  3. Update of the role of Nuclear Medicine techniques in the pre-surgical localization of primary hyperparathyroidism

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 38, Núm. 2, pp. 123-135

2017

  1. 18F-FDG PET/CT in the clinical management of patients with lymphoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 36, Núm. 5, pp. 312-321

  2. Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma

    Cancer Medicine, Vol. 6, Núm. 11, pp. 2507-2514

  3. Mediastinal paraganglioma detected by 111in-Pentetreotide scintigraphy and SPECT/TC. A case report

    Revista ORL, Vol. 8, Vol. 4, pp. 249-252

2016

  1. Validation of the Monte Carlo simulation of a Siemens Biograph mCT PET

    Springer Proceedings in Physics

2015

  1. A novel, fully automated, observer-independent program for semiquantifying striatal 123I-FP-CIT uptake

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 34, Núm. 2, pp. 89-94

2013

  1. Estimation of the total effective dose from low-dose CT scans and radiopharmaceutical administrations delivered to patients undergoing SPECT/CT explorations

    Annals of Nuclear Medicine, Vol. 27, Núm. 7, pp. 610-617